Journal of Vascular Surgery
Volume 50, Issue 5 , Pages 1159-1169, November 2009

The effect of left subclavian artery coverage on morbidity and mortality in patients undergoing endovascular thoracic aortic interventions: A systematic review and meta-analysis

  • Adnan Z. Rizvi, MD

      Affiliations

    • Knowledge and Encounter Research Unit, Mayo Clinic, Rochester, Minn
    • Abbott Northwestern Hospital/Minneapolis Heart Institute Foundation, Minneapolis, Minn
  • ,
  • M. Hassan Murad, MD, MPH

      Affiliations

    • Knowledge and Encounter Research Unit, Mayo Clinic, Rochester, Minn
    • Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, Rochester, Minn
    • Corresponding Author InformationReprint requests: M. Hassan Murad, MD, MPH, Senior Associate Consultant, Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, 200 First St. SW, Rochester, MN 55905
  • ,
  • Ronald M. Fairman, MD

      Affiliations

    • Division of Vascular Surgery and Endovascular Therapy, Hospital of the University of Pennsylvania, Philadelphia, Penn
  • ,
  • Patricia J. Erwin, MLS

      Affiliations

    • Knowledge and Encounter Research Unit, Mayo Clinic, Rochester, Minn
  • ,
  • Victor M. Montori, MD, MSc

      Affiliations

    • Knowledge and Encounter Research Unit, Mayo Clinic, Rochester, Minn
    • Division of Endocrinology, Mayo Clinic, Philadelphia, Penn

Received 1 September 2009; accepted 1 September 2009.

Objectives

Thoracic endografts (stent grafts) have emerged as a less invasive modality to treat various thoracic aortic lesions. The intentional coverage of the left subclavian artery (LSA) during the placement of these endografts is associated with several complications including stroke, spinal cord ischemia, and arm ischemia. In this review, we synthesize the available evidence regarding the complications associated with LSA coverage.

Methods

We searched electronic databases (MEDLINE and EMBASE) from January 1990 through February 2008 for studies that included patients who received thoracic endografts and had intentional LSA coverage. Eligible studies had a control group that either received the endograft without LSA coverage or had primary revascularization prior to coverage. Two independent reviewers determined trial eligibility and extracted descriptive, methodological and outcome data from each eligible study. Meta-analyses estimated Peto odds ratio (OR) and 95% confidence intervals (CI) to describe the strength of association between coverage and complications; the I2 statistic described the proportion of inconsistency of treatment effect among studies not due to chance.

Results

We found 51 eligible observational studies. LSA coverage was associated with significant increase in the risk of arm ischemia (OR 47.7; CI, 9.9-229.3; I2 = 72%, 19 studies) and vertebrobasilar ischemia (OR 10.8; CI, 3.17-36.7; I2 = 0%; eight studies); and nonsignificant increase in the risk of spinal cord ischemia (OR 2.69; CI, 0.75-9.68; I2 = 40%; eight studies) and anterior circulation stroke (OR 2.58; CI, 0.82-8.09; I2 = 64%, 13 studies). There were no significant associations between LSA coverage and death, myocardial infarction, or transient ischemic attacks. The incidence of phrenic nerve injury as a complication of primary revascularization was 4.40% (CI, 1.60%-12.20%). Data on perioperative infection were sparse and rarely reported.

Conclusions

Very low quality evidence suggests that LSA coverage increases the risk of arm ischemia, vertebrobasilar ischemia, and possibly spinal cord ischemia and anterior circulation stroke.

 

 Funded by a contract from the Society for Vascular Surgery. Drs. Rizvi and Murad equally contributed to this systematic review.

 Competition of interest: none.

PII: S0741-5214(09)01824-2

doi:10.1016/j.jvs.2009.09.002

Journal of Vascular Surgery
Volume 50, Issue 5 , Pages 1159-1169, November 2009